Inhaled muscarinic antagonists for respiratory diseases: a review of patents and current developments (2006 – 2010)

Author： Prat Maria Gavaldà Amadeu Fonquerna Silvia Miralpeix Montserrat

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.10, 2011-10, pp. : 1543-1573

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel CRTH2 antagonists: a review of patents from 2006 to 2009

By Ulven Trond Kostenis Evi

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1505-1530

Informa Healthcare

Access to resources Recommend Favorite

Inhaled Muscarinic Acetylcholine Receptor Antagonists for Treatment of COPD

Current Medicinal Chemistry, Vol. 20, Iss. 12, 2013-06 ,pp. : 1464-1476

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinin NK2 receptor antagonists. A patent review (2006 – 2010)

By Altamura Maria

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 1, 2012-01 ,pp. : 57-77

Informa Healthcare

Access to resources Recommend Favorite

A survey of small molecule glucagon receptor antagonists from recent patents (2006 –– 2010)

By Shen Dong-Ming Lin Songnian Parmee Emma R

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 8, 2011-08 ,pp. : 1211-1240

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase-4 inhibitors: a review of current developments (2010 - 2012)

By Gavaldà Amadeu

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 8, 2013-08 ,pp. : 997-1016

Informa Healthcare

Access to resources Recommend Favorite